SILVER SPRING, Md. (Dec. 13, 2017) - The nonprofit International Partnership for Microbicides (IPM) announced today the start of the first clinical trial of vaginal rings designed to slowly release ...
The International Partnership for Microbicides (IPM) announced today that it has received exclusive worldwide rights to a promising HIV prevention medicine called dapivirine from Janssen R&D Ireland, ...
First clinical trial of IPM's dual-purpose vaginal ring builds on promising microbicide technology to address overlapping threats to women's sexual and reproductive health SILVER SPRING, Md. (May 3, ...
The International Partnership for Microbicides (IPM) announced today that it has received two competitive five-year awards with a combined US$40 million ceiling from the US Agency for International ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback